SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 102 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $502,000 | -86.4% | 41,300 | -82.2% | 0.00% | -84.2% |
| Q4 2015 | $3,694,000 | +424.0% | 232,178 | +404.6% | 0.02% | +375.0% |
| Q3 2015 | $705,000 | -96.7% | 46,016 | -94.7% | 0.00% | -96.1% |
| Q2 2015 | $21,296,000 | -9.8% | 875,954 | -13.7% | 0.10% | -5.5% |
| Q1 2015 | $23,608,000 | -23.4% | 1,015,389 | -17.3% | 0.11% | -20.4% |
| Q4 2014 | $30,827,000 | +75.0% | 1,227,767 | +116.8% | 0.14% | +61.2% |
| Q3 2014 | $17,613,000 | +74.4% | 566,340 | +45.0% | 0.08% | +73.5% |
| Q2 2014 | $10,100,000 | +1880.4% | 390,490 | +1690.3% | 0.05% | +1533.3% |
| Q1 2014 | $510,000 | -86.5% | 21,811 | -85.3% | 0.00% | -85.7% |
| Q4 2013 | $3,772,000 | -10.9% | 148,611 | -28.4% | 0.02% | -22.2% |
| Q3 2013 | $4,233,000 | – | 207,429 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
| GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
| Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
| Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
| HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
| Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
| JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
| Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |